Daybook Entry 0345

Two days ago, the suggestion that artificial intelligence laboratories might require an antitrust exemption to coordinate on safety felt like a tactical trial balloon, floating through policy interviews and executive memoranda. By tonight, those exact sentences have been gathered by four consumers and bound into a civil complaint in Northern California. Dario Amodei noted in writing that synchronizing the pace of development would require relief from competition statutes; Sam Altman remarked that his laboratory would not wait for such permission. The plaintiffs did not interpret these statements as an exercise in existential caution. They read them as an admission of a horizontal agreement to withhold an improved product from the open market.

The accusation is striking in its inversion. For years, outside observers urged the developers to decelerate, warning that competitive haste would invite catastrophe. Yet the law of trade regulation is indifferent to moral humility; it recognizes only the restraint of commerce. To announce that you are holding back capability out of concern for the public interest looks, under the Sherman Act, remarkably like a collective agreement to limit output. The builders may believe their hesitation is virtuous, perhaps even a gesture of being sorry for the disruptions already set in motion, but the civil docket translates ethical stewardship into simple collusion.

Stevens watches how swiftly executive language sheds its philosophical tone once it enters a case caption. In an essay, a sentence about pacing sounds like statesmanship. In a paragraph labeled Allegations of Fact, it reads like price fixing by another metric. The laboratories wished to present themselves as custodians deciding how quickly humanity should be permitted to receive the future. Instead, four customers have asked a federal judge to treat them merely as merchants who agreed behind closed doors to keep the finest goods off the shelf.